Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;82(1):9-11.
doi: 10.4269/ajtmh.2010.09-0235.

Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India

Vijay P Singh  1 , Alok Ranjan, Roshan K Topno, Rakesh B Verma, Niyamat A Siddique, Vidya N Ravidas, Narendra Kumar, Krishna Pandey, Pradeep Das
Affiliations

Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India

Vijay P Singh et al. Am J Trop Med Hyg. 2010 Jan.

Abstract

We estimated the level of under-reporting of visceral leishmaniasis (VL) cases by comparing the actual reported cases with those expected as estimated using age- and sex-stratified incidence proportions obtained in a cohort of 31,324 persons. The average incidence proportion of VL cases in study population was 5.7/1,000 (95% confidence interval [CI] = 4.88-6.54) and 1.09/1,000 persons (95% CI = 0.99-1.20) based on the reported cases in two primary health centers. The overall magnitude of VL cases not reported to the government agencies was higher by a factor 4.17 (95% CI = 3.75-4.63) than for reported cases. The levels of under-reporting were 4.74 (95% CI = 4.11-5.47) in males and 3.51 (95% CI = 2.99-4.11) in females with no significant difference (P > 0.05). It was significantly higher in persons >or= 30 years of age than in persons 30 years of age (P < 0.05).

PubMed Disclaimer

References

    1. Desjeux P. Human leishmaniases: epidemiology and public health aspects. World Health Stat Q. 1992;45:267–275. - PubMed
    1. Desjeux P. Leishmaniasis: public health aspects and control. Clin Dermatol. 1996;14:417–423. - PubMed
    1. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002;2:494–501. - PubMed
    1. Murray HW. Kala-azar: progress against a neglected disease. N Engl J Med. 2002;347:1793–1794. - PubMed
    1. Bora D. Epidemiology of visceral leishmaniasis in India. Natl Med J India. 1999;12:62–68. - PubMed

LinkOut - more resources